253 related articles for article (PubMed ID: 35739510)
1. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.
Cao P; Wu JY; Zhang JD; Sun ZJ; Zheng X; Yu BZ; Cao HY; Zhang FL; Gao ZH; Wang W
BMC Cancer; 2022 Jun; 22(1):691. PubMed ID: 35739510
[TBL] [Abstract][Full Text] [Related]
2. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma.
Xu C; Zeng H; Fan J; Huang W; Yu X; Li S; Wang F; Long X
BMC Cancer; 2022 Mar; 22(1):264. PubMed ID: 35279104
[TBL] [Abstract][Full Text] [Related]
3. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
4. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
5. Construction of exosome-related genes risk model in kidney cell carcinoma predicts prognosis and immune therapy response.
Gao C; Huang W; Su Q; Li J; Wang W; Qi Y; Du E; Zhang Z
Aging (Albany NY); 2024 May; 16(9):7622-7646. PubMed ID: 38728235
[TBL] [Abstract][Full Text] [Related]
6. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
[TBL] [Abstract][Full Text] [Related]
7. The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma.
Xu F; Guan Y; Xue L; Huang S; Gao K; Yang Z; Chong T
BMC Cancer; 2020 Dec; 20(1):1207. PubMed ID: 33287763
[TBL] [Abstract][Full Text] [Related]
8. Identification and Verification of Tumor Immune Microenvironment-Related Prognostic Genes in Kidney Renal Clear Cell Carcinoma.
Kong G; Wang Y; Huang Y; Shi Z
Biomed Res Int; 2022; 2022():5563668. PubMed ID: 35127943
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies.
Wang H; Liu Y; Tang A; Zhang X
Eur J Med Res; 2024 May; 29(1):292. PubMed ID: 38773560
[TBL] [Abstract][Full Text] [Related]
10. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
de Velasco G; Culhane AC; Fay AP; Hakimi AA; Voss MH; Tannir NM; Tamboli P; Appleman LJ; Bellmunt J; Kimryn Rathmell W; Albiges L; Hsieh JJ; Heng DY; Signoretti S; Choueiri TK
Oncologist; 2017 Mar; 22(3):286-292. PubMed ID: 28220024
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
12. A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma.
Li F; Hu W; Zhang W; Li G; Guo Y
Dis Markers; 2020; 2020():8352809. PubMed ID: 32184905
[TBL] [Abstract][Full Text] [Related]
13. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
14. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
15. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
16. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
[TBL] [Abstract][Full Text] [Related]
17. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
18. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
Lin J; Lin Y; Huang Z; Li X
Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963
[TBL] [Abstract][Full Text] [Related]
19. Immune-related prognostic genes signatures in the tumor microenvironment of sarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
Math Biosci Eng; 2021 Mar; 18(3):2243-2257. PubMed ID: 33892543
[TBL] [Abstract][Full Text] [Related]
20. The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma.
Xu F; Guan Y; Zhang P; Xue L; Yang X; Gao K; Chong T
Genes Genomics; 2020 Sep; 42(9):1055-1066. PubMed ID: 32725578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]